Healthequity Inc (HQY) Shares Bought by Strs Ohio

Share on StockTwits

Strs Ohio increased its stake in shares of Healthequity Inc (NASDAQ:HQY) by 100.0% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 7,800 shares of the company’s stock after purchasing an additional 3,900 shares during the period. Strs Ohio’s holdings in Healthequity were worth $585,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. New York State Teachers Retirement System raised its position in shares of Healthequity by 2.5% during the 2nd quarter. New York State Teachers Retirement System now owns 34,957 shares of the company’s stock worth $2,625,000 after purchasing an additional 841 shares during the last quarter. Mason Street Advisors LLC grew its stake in Healthequity by 7.0% during the 1st quarter. Mason Street Advisors LLC now owns 14,307 shares of the company’s stock valued at $866,000 after acquiring an additional 934 shares in the last quarter. Aperio Group LLC grew its stake in Healthequity by 6.3% during the 2nd quarter. Aperio Group LLC now owns 17,977 shares of the company’s stock valued at $1,350,000 after acquiring an additional 1,064 shares in the last quarter. Keeler Thomas Management LLC grew its stake in Healthequity by 13.5% during the 1st quarter. Keeler Thomas Management LLC now owns 10,100 shares of the company’s stock valued at $611,000 after acquiring an additional 1,200 shares in the last quarter. Finally, Envestnet Asset Management Inc. grew its stake in Healthequity by 22.8% during the 1st quarter. Envestnet Asset Management Inc. now owns 6,677 shares of the company’s stock valued at $416,000 after acquiring an additional 1,239 shares in the last quarter. Hedge funds and other institutional investors own 97.12% of the company’s stock.

In other news, Director Frank Medici sold 15,596 shares of the stock in a transaction that occurred on Tuesday, July 10th. The shares were sold at an average price of $80.15, for a total value of $1,250,019.40. Following the completion of the sale, the director now owns 26,341 shares of the company’s stock, valued at approximately $2,111,231.15. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, VP Darcy G. Mott sold 4,000 shares of the stock in a transaction that occurred on Monday, August 20th. The shares were sold at an average price of $86.37, for a total transaction of $345,480.00. Following the completion of the sale, the vice president now directly owns 99,200 shares of the company’s stock, valued at approximately $8,567,904. The disclosure for this sale can be found here. In the last three months, insiders sold 49,500 shares of company stock valued at $3,932,081. Corporate insiders own 4.00% of the company’s stock.

Healthequity stock opened at $96.92 on Thursday. Healthequity Inc has a 1-year low of $42.92 and a 1-year high of $97.93. The company has a market capitalization of $5.85 billion, a PE ratio of 179.48, a PEG ratio of 3.92 and a beta of 1.47.

Healthequity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, September 4th. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.12. Healthequity had a net margin of 22.91% and a return on equity of 13.47%. The business had revenue of $71.10 million during the quarter, compared to analysts’ expectations of $69.84 million. During the same quarter in the prior year, the company posted $0.27 EPS. The business’s revenue for the quarter was up 25.0% on a year-over-year basis. sell-side analysts forecast that Healthequity Inc will post 0.72 earnings per share for the current year.

Several analysts recently issued reports on the stock. Bank of America cut shares of Healthequity from a “buy” rating to a “neutral” rating and set a $105.00 price objective for the company. in a research note on Thursday. They noted that the move was a valuation call. Oppenheimer upped their price objective on shares of Healthequity from $85.00 to $104.00 and gave the company an “outperform” rating in a research note on Wednesday. Barrington Research reaffirmed an “outperform” rating and set a $100.00 price objective on shares of Healthequity in a research note on Wednesday. They noted that the move was a valuation call. KeyCorp upped their price objective on shares of Healthequity from $72.00 to $82.00 and gave the company an “overweight” rating in a research note on Tuesday, June 5th. Finally, Citigroup reaffirmed a “buy” rating and set a $110.00 price objective on shares of Healthequity in a research note on Wednesday. Four analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company. Healthequity has a consensus rating of “Buy” and an average target price of $92.08.

Healthequity Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Story: Growth Stocks

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply